139 related articles for article (PubMed ID: 35289445)
21. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
[TBL] [Abstract][Full Text] [Related]
22. Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers.
Xia P; Zhang L; Li P; Liu E; Li W; Zhang J; Li H; Su X; Jiang G
J Transl Med; 2021 Jul; 19(1):308. PubMed ID: 34271921
[TBL] [Abstract][Full Text] [Related]
23. ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase-Altered Mesenchymal Tumors.
Gestrich CK; Davis JL; Biederman L; John I; Alaggio R; Giovannoni I; Arnold MA; Shenoy A; Tchakarov A; Al-Ibraheemi A
Mod Pathol; 2023 Dec; 36(12):100334. PubMed ID: 37726067
[TBL] [Abstract][Full Text] [Related]
24. Aneurysmal fibrous histiocytomas with recurrent rearrangement of the PRKCD gene and LAMTOR1-PRKCD fusions.
Jedrych JJ; Duraisamy S; Karunamurthy A
J Cutan Pathol; 2018 Dec; 45(12):966-968. PubMed ID: 30094855
[No Abstract] [Full Text] [Related]
25. Spitz nevus with EHBP1-ALK fusion and distinctive membranous localization of ALK.
Bahrani E; Kunder CA; Teng JM; Brown RA; Rieger KE; Novoa RA; Cloutier JM
J Cutan Pathol; 2022 Jun; 49(6):584-588. PubMed ID: 35113459
[TBL] [Abstract][Full Text] [Related]
26. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.
Gascoyne RD; Lamant L; Martin-Subero JI; Lestou VS; Harris NL; Müller-Hermelink HK; Seymour JF; Campbell LJ; Horsman DE; Auvigne I; Espinos E; Siebert R; Delsol G
Blood; 2003 Oct; 102(7):2568-73. PubMed ID: 12763927
[TBL] [Abstract][Full Text] [Related]
27. Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait.
Wang XT; Fang R; Ye SB; Zhang RS; Li R; Wang X; Ji RH; Lu ZF; Ma HH; Zhou XJ; Xia QY; Rao Q
Pathol Res Pract; 2019 Nov; 215(11):152651. PubMed ID: 31563285
[TBL] [Abstract][Full Text] [Related]
28. Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions.
Jedrych J; Nikiforova M; Kennedy TF; Ho J
Br J Dermatol; 2015; 172(5):1427-9. PubMed ID: 25413595
[No Abstract] [Full Text] [Related]
29. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
[TBL] [Abstract][Full Text] [Related]
30. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
Chopra S; Maloney N; Wang WL
Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
[TBL] [Abstract][Full Text] [Related]
31. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
32. An Unusual Case of an ALK-Negative Epithelioid Fibrous Histiocytoma in the External Auditory Canal.
Leff M; Quimby A; Morgan E; Brant JA
Laryngoscope; 2024 Jan; ():. PubMed ID: 38264975
[TBL] [Abstract][Full Text] [Related]
33. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
[TBL] [Abstract][Full Text] [Related]
34. Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses: Solitary Soft Tissue Histiocytomas in Children With a Novel CLTC::SYK Fusion.
Crowley HM; Georgantzoglou N; Tse JY; Williams EA; Mata DA; Martin SS; Guitart J; Bridge JA; Linos K
Am J Surg Pathol; 2023 Oct; 47(10):1108-1115. PubMed ID: 37522373
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
Lin C; Shi X; Yang S; Zhao J; He Q; Jin Y; Yu X
Lung Cancer; 2019 May; 131():62-68. PubMed ID: 31027700
[TBL] [Abstract][Full Text] [Related]
36. Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
Chang JC; Zhang L; Drilon AE; Chi P; Alaggio R; Borsu L; Benayed R; Travis WD; Ladanyi M; Antonescu CR
J Thorac Oncol; 2019 May; 14(5):825-834. PubMed ID: 30550870
[TBL] [Abstract][Full Text] [Related]
37. Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.
Vendrell JA; Taviaux S; Béganton B; Godreuil S; Audran P; Grand D; Clermont E; Serre I; Szablewski V; Coopman P; Mazières J; Costes V; Pujol JL; Brousset P; Rouquette I; Solassol J
Sci Rep; 2017 Oct; 7(1):12510. PubMed ID: 28970558
[TBL] [Abstract][Full Text] [Related]
38. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
[TBL] [Abstract][Full Text] [Related]
40. ALK detection in lung cancer: identification of atypical and cryptic ALK rearrangements using an optimal algorithm.
Liu Y; Wu S; Shi X; Liang Z; Zeng X
J Cancer Res Clin Oncol; 2020 May; 146(5):1307-1320. PubMed ID: 32128622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
